Results 21 to 30 of about 73,124 (298)

Development and applicability of a dignity‐centred palliative care programme for people with idiopathic pulmonary fibrosis: A qualitative‐driven mixed methods study

Nursing Open, 2023
Aims This study evaluated the acceptability of a dignity‐centred palliative care programme for people with idiopathic pulmonary fibrosis by converging perceptions of living with idiopathic pulmonary fibrosis qualitative data and quantitative data. Design
Yasuko Igai, Sarah E. Porter
doaj   +1 more source

Pirfenidone in idiopathic pulmonary fibrosis:expert panel discussion on the management of drug-related adverse events [PDF]

, 2014
Pirfenidone is currently the only approved therapy for idiopathic pulmonary fibrosis, following studies demonstrating that treatment reduces the decline in lung function and improves progression-free survival.
Per M. Hellström, Groves, Richard, Michael Kreuter, Toby M. Maher, Maher, Toby M, Dewint, P. (Pieter), Sarafidis, A. (Alexandre), Vancheri, C. (Carlo), Egan, Jim JJ, Bendstrup, Elisabeth, Maher, T.M. (Toby), Bendstrup, E. (Elisabeth), Sarafidis, Alexandre, Egan, Jim J J, Vancheri, Carlo, Jim J. J. Egan, Costabel, Ulrich, Ferguson, James, Vincent Cottin, Nordlind, K. (Klas), Cottin, V. (Vincent), Hellström, Per M, Maher, Toby M., Carlo Vancheri, Richard Groves, Groves, R. (Richard), Costabel, U., Klas Nordlind, Dewint, Pieter, Nordlind, Klas, Cottin, Vincent, Ulrich Costabel, Ferguson, J.J. (James), Hellström, A.-L., Alexandre Sarafidis, Pieter Dewint, Egan, Jim J. J., Elisabeth Bendstrup, Kreuter, M. (Michael), Maria Molina-Molina, Molina-Molina, M. (Maria), James Ferguson, Kreuter, Michael, Egan, J.J.J. (Jim J.), Molina-Molina, Maria, Hellström, Per M., Hellström, Per M.,   +46 more
core   +1 more source

Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?

Frontiers in Immunology, 2021
The immune system is receiving increasing attention for interstitial lung diseases, as knowledge on its role in fibrosis development and response to therapies is expanding. Uncontrolled immune responses and unbalanced injury-inflammation-repair processes
Chiel van Geffen, Astrid Deißler, Astrid Deißler, Markus Quante, Harald Renz, Harald Renz, Dominik Hartl, Dominik Hartl, Saeed Kolahian, Saeed Kolahian, Saeed Kolahian   +10 more
doaj   +1 more source

A sigmoidal fit for pressure-volume curves of idiopathic pulmonary fibrosis patients on mechanical ventilation: clinical implications

Clinics, 2011
OBJECTIVE: Respiratory pressure-volume curves fitted to exponential equations have been used to assess disease severity and prognosis in spontaneously breathing patients with idiopathic pulmonary fibrosis.
Juliana C. Ferreira, Fabio E. M. Benseñor, Marcelo J. J. Rocha, Joao M. Salge, R. Scott Harris, Atul Malhotra, Ronaldo A. Kairalla, Robert M. Kacmarek, Carlos R. R. Carvalho   +8 more
doaj   +1 more source

Acute worsening of native lung fibrosis after single lung transplantation for pulmonary fibrosis: two case reports

Journal of Medical Case Reports, 2022
Background In patients receiving single lung transplantation for idiopathic pulmonary fibrosis, worsening of fibrosis of the native lung is usually progressive over time, with no significant effects on gas exchange.
Tiphaine Goletto, Sixtine Decaux, Vincent Bunel, Gaëlle Weisenburger, Jonathan Messika, Samer Najem, Chahine Medraoui, Cendrine Godet, Marie Pierre Debray, Brice Lortat-Jacob, Pierre Mordant, Yves Castier, Lila Bouadma, Raphael Borie, Hervé Mal   +14 more
doaj   +1 more source

Pulmonary fibrosis: “idiopathic” is not “cryptogenic” [PDF]

European Respiratory Journal, 2019
The additional argument advanced by Professor Cottin for retention of the term “idiopathic pulmonary fibrosis” is highly persuasivehttp://ow.ly ...
Wells, Athol U, Brown, Kevin K, Flaherty, Kevin R, Kolb, Martin, Thannickal, Victor J, Vancheri C   +5 more
openaire   +2 more sources

Cough in Idiopathic Pulmonary Fibrosis [PDF]

Frontiers in Rehabilitation Sciences, 2021
Chronic cough is experienced by most patients with idiopathic pulmonary fibrosis (IPF). It is often the first symptom and is associated with reduced quality of life, increased rates of depression and anxiety, more severe physiological impairment, and disease progression.
Jennifer Mann, Jennifer Mann, Jennifer Mann, Nicole S. L. Goh, Nicole S. L. Goh, Nicole S. L. Goh, Anne E. Holland, Anne E. Holland, Anne E. Holland, Yet Hong Khor, Yet Hong Khor, Yet Hong Khor   +11 more
openaire   +3 more sources

Akt1 regulates pulmonary fibrosis via modulating IL-13 expression in macrophages

Innate Immunity, 2019
Idiopathic pulmonary fibrosis is a progressive interstitial pneumonia characterised by fibroblast accumulation, collagen deposition and extracellular matrix (ECM) remodelling.
Yunjuan Nie, Yudong Hu, Kaikai Yu, Dan Zhang, Yinze Shi, Yaolin Li, Lei Sun, Feng Qian   +7 more
doaj   +1 more source

Diagnostic value of combining high resolution computed tomography with pulmonary artery systolic pressure for assessment of idiopathic pulmonary fibrosis [PDF]

Minia Journal of Medical Research
Background and objective: Idiopathic interstitial pneumonias (IIPs) are a heterogeneous group of non-neoplastic disorders resulting from the deterioration of lung tissue.
Alyaa Ali, Mohammed Abdelnaaem, Sara Ragaey, Ahmed kasem   +3 more
doaj   +1 more source

Management of Idiopathic Pulmonary Fibrosis [PDF]

Clinics in Chest Medicine, 2012
Idiopathic pulmonary fibrosis (IPF) is a deadly progressive lung disease without an effective standard treatment approach. Because of the complexity and uncertainties of IPF treatment, therapeutic decisions need to be tailored to the individual patient, after discussing the potential benefits and pitfalls.
CERRI, Stefania, SPAGNOLO, Paolo, F. Luppi, RICHELDI, Luca   +3 more
openaire   +5 more sources